The association of baseline N-terminal pro-B-type natriuretic peptide with short and long-term prognosis following percutaneous coronary intervention in non-ST segment elevation acute coronary syndrome with multivessel coronary artery disease: a retrospective cohort study

Table 2 Clinical outcomes of different baseline NT-proBNP levels

In-hospital outcomes	NT-proBNP (Q1 < 96 pg/ml) N = 257	NT-proBNP (328 pg/ml < Q3 < 1287 pg/ml) N = 255	NT-proBNP (Q4 > 1287 pg/ml) N = 255	P-value
All-cause death	0 (0.0%)	1 (0.4%)	11 (4.3%)	< 0.001
Stroke	0 (0.0%)	2 (0.8%)	3 (1.2%)	0.142
MI	2 (0.8%)	2 (0.8%)	3 (1.2%)	0.434
MACE	2 (0.8%)	4 (1.6%)	16 (6.3%)	< 0.001

MACE major adverse cardiovascular events, MI myocardial infarction, NT-proBNP N-terminal pro-B-type natriuretic peptide

ISSN: 1471-2261